全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Hitoshi Ishii , Yuki Suzaki , Yuko Miyata
来源:[J].Diabetes Therapy, 2017, Vol.8 (6), pp.1415-1425Springer
摘要:Long-term glycemic control in type 2 diabetes is critical to prevent or delay the onset of macrovascular and microvascular complications. Medication adherence is an integral component of type 2 diabetes management. Minimizing the dosing frequency of antidiabetic drugs may re...
作者:Yuko Miyata , Kiyofumi Sasai
来源:[J].Clinical Therapeutics(IF 2.23), 2012, Vol.34 (4), pp.838-848Elsevier
摘要:Abstract(#br)Background(#br)Blood pressure is reported to be insufficiently controlled in >50% of patients with hypertension. Guidelines for the management of hypertension recommend using drugs with different mechanisms of action when >1 agent is needed to achieve the blood ...
作者:... Yuki Suzaki , Yuko Miyata , Shingo Matsui
来源:[J].Diabetes Therapy, 2019, Vol.10 (4), pp.1369-1380Springer
摘要:Abstract(#br) Introduction(#br)Dipeptidyl peptidase-4 (DPP-4) inhibitors are an established treatment in type 2 diabetes mellitus (T2DM). The objective of this study was to investigate differences in quality of life (QOL) and treatment satisfaction among treatment-naïve T2DM...
作者:Yuko Miyata , Shingo Matsui
来源:[J].Atherosclerosis(IF 3.706), 2020, Vol.292, pp.163-170Elsevier
摘要:Abstract(#br)Background and aims(#br)We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) after 8 weeks of omega-3 fatty acid ethyl esters (Omega-3) treatment, using hi...
作者:Yuko Miyata , Kenkichi Sugiura ...
来源:[J].Journal of Cardiology(IF 2.298), 2013, Vol.61 (4), pp.267-274Elsevier
摘要:Abstract(#br)Background(#br)Chronic heart failure (CHF) is an increasingly common cardiovascular disease despite recent advances in its diagnosis and management.(#br)Methods and results(#br)A multicenter, open-label study was designed to assess the efficacy and safety of 60-week ...
作者:Yuko Miyata , Ken-ichi Saeki ...
来源:[J].Mut.Res.-Genetic Toxicology and Environmental Mutagenesis(IF 2.22), 1998, Vol.414 (1), pp.165-169Elsevier
摘要:Abstract(#br)Quinoline, a hepatocarcinogen, mutates the bacterial tester strains in the presence of the rat liver microsomal enzymes and induces GST-P (placental glutathione S -transferase)-positive foci in a medium-term bioassay system for hepatocarcinogenesis. On the other...
作者:Yuko Miyata , Megumi Terada ...
来源:[J].Mut.Res.-Genetic Toxicology and Environmental Mutagenesis(IF 2.22), 1999, Vol.444 (2), pp.321-336Elsevier
摘要:Abstract(#br)As part of a collaborative study, the Mammalian Mutagenesis Study Group (MMS), a sub-organization of the Environmental Mutagen Society of Japan (JEMS) conducted mutagenicity tests in Muta™Mouse. Using a positive selection method, we studied the organ-specificity...
作者:Yuko Miyata , Ken-ichi Saeki ...
来源:[J].Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis(IF 3.902), 2000, Vol.456 (1), pp.73-81Elsevier
摘要:Abstract(#br)Quinoline is carcinogenic to the liver in rodents, but it is not clear whether it acts by a genotoxic mechanism. We previously demonstrated that quinoline does induce gene mutation in the liver of lambda/ lacZ transgenic mice. In the present report, we reveal the mol...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×